BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9479879)

  • 1. Overexpression of cyclin D1 in chronic lymphoproliferation with t(11; 14)(q13; q32).
    Takahashi T; Hayashi T; Minami T; Adachi M; Hinoda Y; Imai K
    Int J Hematol; 1997 Dec; 66(4):521-3. PubMed ID: 9479879
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32).
    Shimazaki C; Goto H; Araki S; Tatsumi T; Takahashi R; Hirai H; Kikuta T; Yamagata N; Ashihara E; Inaba T; Fujita N; Suzuki R; Nakagawa M
    Int J Hematol; 1997 Jul; 66(1):111-5. PubMed ID: 9220667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
    Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
    Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation.
    Hosokawa Y; Joh T; Maeda Y; Arnold A; Seto M
    Int J Cancer; 1999 May; 81(4):616-9. PubMed ID: 10225453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14).
    Sonoki T; Matsuzaki H; Satterwhite E; Nakazawa N; Hata H; Tucker PW; Taniwaki M; Kuribayashi N; Harada N; Matsuno F; Mitsuya H
    Acta Haematol; 1999; 101(4):197-201. PubMed ID: 10436301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
    Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
    Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).
    Kobayashi H; Kitano K; Saito H; Aoki K; Narita A; Terada N; Sonoyama M; Uchimaru K; Machii T; Motokura T
    Cancer Genet Cytogenet; 1995 Oct; 84(1):69-72. PubMed ID: 7497446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent in situ hybridization analysis of an atypical t(11;14)(q13;q32) without expression of the cyclin D1 gene.
    Raynaud SD; Gratecos N; Simon MP; Chischportich M; Grosgeorge J; Gaudray P; Ayraud N
    Leukemia; 1993 Nov; 7(11):1924-7. PubMed ID: 8231265
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
    Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
    Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia with translocation (11;20)(q13;q11) and overexpression of cyclin D1.
    Ishida F; Kitano K; Ichikawa N; Ito T; Kohara Y; Taniguchi T; Motokura T; Kiyosawa K
    Leuk Res; 1999 Aug; 23(8):763-5. PubMed ID: 10456674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
    Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
    Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].
    Fukushima Y; Miura I; Niitsu H; Hashimoto K; Takatsu H; Akihama T; Miura A
    Rinsho Ketsueki; 1986 Nov; 27(11):2124-30. PubMed ID: 3820630
    [No Abstract]   [Full Text] [Related]  

  • 18. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
    Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
    Fonseca R; Hoyer JD; Aguayo P; Jalal SM; Ahmann GJ; Rajkumar SV; Witzig TE; Lacy MQ; Dispenzieri A; Gertz MA; Kyle RA; Greipp PR
    Leuk Lymphoma; 1999 Nov; 35(5-6):599-605. PubMed ID: 10609798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.